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ABSTRACT 
Magnetic nanoparticles control neural stem cell behavior  
in normal and ischemic brain 
Seokhwan Yun 
Department of Medical Science 
The Graduate School, Yonsei University 
(Directed by Professor Kook In Park) 
Over the past few decades, the establishment of neural stem cells as a long-lasting 
source of neurons and glial cells had led to the development of novel therapeutic 
approaches for a variety of neurodegenerative disorders such as brain stroke. Neural stem 
cells graft promoted brain protection, regeneration and functional recovery. Nonetheless, 
the therapeutic benefits of neural stem cells had been limited due to their poor in vivo 
control of migration, engraftment and differentiation into target tissue. 
Recently, nanotechnologies are emerging platforms that could be useful in measuring, 
understanding and manipulating stem cells. Advanced nanoparticles, carbone nanotubes, 
and polyplexes have been widely used for stem cell labeling, tracking, differentiation and 
transplantation. 
Here we demonstrated magnetotactic human neural stem cells that can be directed to 
the desired target lesion via non-invasive, remote magnetic guidance. In the presence of 
an external magnetic field, the advanced magnetic nanoparticle allowed neural stem cells 
to possess strong attraction forces, which was sufficient for migration, and highly 
sensitive MRI contrast that enabled long-term tracking of neural stem cells. We found the 
enhanced migration and engraftment and promoted neuronal differentiation of non-
invasively injected magnetotactic neural stem cells in animal stroke model which resulted 
in improved neurological function and pathology. 
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I. INTRODUCTION 
 
Worldwide, around 15 million people develope a stroke every year and with about 5 
million deaths, stroke is the second most common cause of death and a major cause of 
long-term disability.1,2 It is estimate that about 25% of people older than 85 years will 
develop stroke. In the past decade, remarkable progress in understanding stroke 
pathophysiology has been made, especially in ischemic stroke,1,3 which makes up 80% of 
all cases.3 These advances have led to the identification of more than 1,000 molecules 
with brain-protective effects from experimental models and to the implementation of 
more than 250 clinical trials.4 Despite all these efforts, there have been no effective 
treatment. Current therapeutic approaches, such as the use of thrombolytics, benefit only 
1% to 4% of patients.4 Recent evidence suggested that the transplantation of stem cells 
derived from cord blood or bone marrow or brain-derived neural stem cell resulted in 
functional recovery in experimental models of stroke.1-3 
Like other stem cells, neural stem cells (NSCs) possess the unique property of self-
renewal and the ability to generate differentiated progeny that can be utilized to generate 
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both neurons and glial cells.5-7 Thus, NSCs transplanted to neuronal injury or 
degeneration in the central nervous system (CNS) can not only promote the replacement 
of damaged tissue, but also support neuroprotection by preventing tissue injury and 
rescuing host cells.8,9 Because of harsh biological environments in areas of pathology, 
NSCs were usually transplanted somewhat distant from target lesions to secure cellular 
viability and engraftment. Owing to the chemotaxic nature of NSCs, they could migrate 
towards diseased areas in response to a chemical gradient induced by lesions.10,11 Because 
the therapeutic effects of NSCs vary depending on homing efficiency to areas of 
pathology, efficient migration with high engraftment and viability is regarded as one of 
the critical requirements for successful stem cell therapy.4,8 However, delivery of stem 
cells through chemotaxis was often limited by low homing efficiency due to complicated 
chemo-attractive mechanisms that hinder accurate manipulation and/or guidance of stem 
cells. Several attempts to overcome such obstacles have been made using a direct 
intracerebral transplantation strategy, which allows for increased efficiency of NSC 
homing.10,12,13 However, this strategy is used reluctantly because of its associated 
invasiveness, which includes craniectomy. 
The term, magnetotaxis, is a composite word of magnet and chemotaxis. Magnetotaxis 
were chosen as an alternative solution of chemotaxis owing to the development of 
magnetic nanoparticle. Zinc-doped iron oxide magnetic nanoparticles (Zn0.4Fe2.6O4, 
ZnMNP, 18 nm diameter) have superparamagnetic properties and higher saturation 
magnetization (Ms) value (161 emu/g) than Ms value of ferumoxide (78emu/g) that have 
been approved by the U. S Food and Drug Administration (FDA).14 ZnMNP gave rise to 
cells not only magnetotactic ability but also provided several biomedical advantages such 
as Magnetic Resonance imaging (MRI) tracking, drug delivery and hyperthermia.15 
To attempt cell based therapy, tracking cellular path in animal model is crucial.16 
Various histological methods provide high resolution of exogenous cell image, but those 
methods could provide information only at the time of sacrificing animal. An important 
goal in stem cell therapy is observation of donor-derived cells in vivo to survey their 
engraftment, location. MRI is one of the powerful tools that is suitable for this purpose. 
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Researchers have tried to use MRI to track transplanted cells.17,18 Superparamagnetic iron 
oxide (SPIO) nanoparticles produce hypo-intense dark signal in T2-weighted image.17,18 
However, visualization cells by MRI in vivo have limits such as false signal by artifact, 
low resolution compared to histologic images. Such obstacles can be overcome by 
ZnMNP due to the strong Ms value. 
Taken advantages of both ZnMNP and NSCs, we transfected ZnMNP to NSCs, and 
intravascular cell injection into middle cerebral artery occlusion (MCAO) animal model 
penentrated the damaged brain through disrupted blood brain barrier (BBB), engraftment 
and migration to ischemic core and penumbra area by static magnetic field. In addition, 
exogenous cells were capable of tracing non-invasively with MRI and bioluminescence 
imaging (BLI). Furthermore, ZnMNP transfection cause neuronal differentiation of NSCs 
through wnt/β-catenin signaling pathway. Combination of these properties, we 
anticipated to regulate, trace exogenous stem cells and discover a new therapeutic stem 
cell application method. 
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II. MATERIALS AND METHODS 
 
1. Culture of human neural stem cells 
 
Human fetal tissue aborted at 13 weeks of gestation was provided with full patient 
consent and the approval of the research ethics committee of Yonsei University College 
of Medicine.19 The method of acquisition confirmed to National Institutes of Health (NIH) 
and Korean Government guidelines. Human NSCs were isolated from fetal telencephalic 
brain tissue by chopping and trypsinization and seeded into tissue culture-treated 100 mm 
plates (Corning, Lowell, MA, USA) at a density of 200,000 cells/ml of serum-free growth 
medium and Ham`s F12 (DMEM/F12; Gibco, Carlsbad, CA, USA) supplemented with 
N2 formulation (Gibco). Mitogenic stimulation was achieved by adding 20ηg/㎖ 
fibroblast growth factor (FGF2; R&D Systems, Minneapolis, MN, USA) and 10ηg/㎖ 
leukemia inhibitory factor (LIF; Sigma, St. Louis, MO, USA). Heparin (8μg/㎖; Sigma) 
was added to stabilize FGF-2 activity.19 All of the cultures were maintained in a 
humidified incubator at 37°C and 5% CO2 in air, and half of the medium was replenished 
every 3-4 days. Passaging was undertaken every 7-8 days by dissociation of bulk 
neurospheres with 0.05% trypsin/EDTA (T/E; Gibco).19 The neurospheres were re-seeded 
into fresh growth medium at a density equivalent to approximately 200,000 cells/㎖. 
Some neurospheres were attached on silane coating slide glass (Mutoglass, Japan) by use 
of cytospin (Shandon, Albany, NY, USA) for NSC characterization. 2uM 5-bromo-2`-
deoxyuridine (BrdU) was added to cultures 48 hours prior to cytospin attachment. 
Attached neurospheres were immunostained with proliferating markers, neural stem cell 
markers and several neurotrophic factors (Table. 1). In differentiated conditions, 
trypsinized single cells were re-seeded in PLL coated 8-well chamber slide (Corning, 
Lowell, MA, USA) and immunostained with lineage specific antibodies (Table. 1).  
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  2.  Firefly luciferase expressing neural stem cells 
 
Recombinant lenti-viruses were produced using transient transfection into 293FT 
cells. Subconfluent 293FT cells were cotransfected with 20 μg pWPI transfer plasmid 
vector containing firefly luciferase (Fluc) with Green Fluorescent Protein (GFP), 15 μg 
psPAX2 packaging construct plasmid and 6 μg pMD2G envelop plasmid by calcium 
phosphate precipitation. The lentiviral plasmid vectors were donated from Trono lab 
(http://tronolab.epfl/ch). After 3 hours, the media was changed with fresh medium, 
recombinant viruses were harvested 48 hours later and viruses were concentrated by 
ultracentrifugation under the sucrose cushion buffer. The virus titer was checked as 
transducing unit (TU) via flow cytometry (Vector Dickson, Dickson city, PA, USA).20 To 
transduce recombinant lenti-viruses, NSCs were seeded onto cell culture dishes (Corning). 
1 hour later, lentiviral particles were added to well. The media was replaced with fresh 
one the next day, and each cells transduced with lentiviral vector were cultured over 1 
month to confirm the stable expression of Fluc and GFP.  
 
3. Synthesis of Zn-doped magnetic nanoparticle 
 
   Zinc doped iron oxide magnetic nanoparticles (Zn0.4Fe2.6O4, ZnMNPs) were prepared 
by thermal decomposition of Fe(acac)3 (Sigma, 353 mg), ZnCl2 (Sigma, 30 mg) and FeCl2 
(Sigma, 40 mg) in octyl ether containing oleic acid and oleylamine. The mixture was 
heated at 300°C for 1 hour. After removing the heat source, the reaction products were 
cooled to room temperature. The color of reaction mixture turned black and we obtained 
18 nm ZnMNPs. Upon addition of ethanol, a black powder was precipitated and isolated 
by centrifugation. The isolated ZnMNPs were dispersed in a solvent such as toluene. The 
organic surfactants on the ZnMNPs surface were removed and exchanged with dextran to 
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make the ZnMNPs dispersed in the aqueous medium completely.14 
Table 1. Antibodies used for immunostaining 
 
Antibodies1 Host Titer Company Domicilli 
β-catenin rabbit 1:200 Cell signaling Danvers, MA, USA 
BDNF rabbit 1:1000 Santacruz Dallas, CA, USA 
BrdU-FITC mouse 1:20 Roche Penzberg, German 
Caspase3 rabbit 1:250 BD Franklin Lakes, NJ, USA 
CD133 goat 1:100 
Santacruz Dallas, CA, USA 
Dcx goat 1:400 
FGF rabbit 1:1000 
GDNF rabbit 1:1000 
GFAP rabbit 1:1500 DAKO Glustrup, Denmark 
GFP rabbit 1:200 Invitrogen Waltham, MA, USA 
hNuc mouse 1:100 Chemicon Darmstadt, German 
KI67 mouse 1:100 DAKO Glustrup, Denmark 
Map2 rabbit 1:500 Cell signaling Danvers, MA, USA 
Nestin rabbit 1:200 
Chemicon Darmstadt, German 
Nestin mouse 1:200 
NGF rabbit 1:1000 Cell signaling Danvers, MA, USA 
NTF3 rabbit 1:1000 
Santacruz Dallas, CA, USA 
NTF4 rabbit 1:1000 
O4 mouse 1:100 
Chemicon Darmstadt, German 
Olig2 rabbit 1:500 
Pax6 mouse 1:100 DSHB Iowa city, IA, USA 
PCNA rabbit 1:100 
Santacruz Dallas, CA, USA 
PDGFR rabbit 1:100 
Sc121 mouse 1:500 SC-proven Newark, CA, USA 
Sox2 rabbit 1:200 Chemicon Darmstadt, German 
Tuj1 rabbit 1:500 Covance Princeton, NJ, USA 
VEGF rabbit 1:1000 Santacruz Dallas, CA, USA 
Vimentin mouse 1:40 Sigma St. Louis, MO, USA 
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1  Antibodies were listed in alphabetical order. 
 
4. Intracellular labeling of Zn-doped magnetic nanoparticle to neural stem cells 
 
For the intracellular labeling of NSCs with ZnMNP, tripsinized single NSCs (or 
Lenti-Fluc-GFP-NSCs) were plated with half volume of growth medium at a final cell 
density of 3×106cells/well in 6well culture plate (Corning). ZnMNP solutions were 
prepared at a 2× concentration in growth medium then poly-L-lysine (PLL; Sigma) from 
stock solution (1 mg/㎖) was added and allowed 5 minutes at RT. 1ml of 2× ZnMNP-
PLL solutions were added to 1ml of NSCs suspensions (final concentration of ZnMNP-
PLL was 15μg/ml in growth medium) and incubated for 48 hours. Cells in growth 
medium without ZnMNP were used as an untreated control. 48 hours later, cells were 
refreshed with new growth medium and incubated for 24 hours more. At the end of the 
incubation, cells were treated with 0.05% T/E (Gibco), triturated mechanically, washed 
three times with Hank’s-HEPES buffer solution (1× Hanks’ balanced salt solution, 10mM 
HEPES, pH 7.4; Gibco). 
For Perl`s prussian blue staining, which indicates the presence of iron, cells were 
treated with 0.05% T/E (Gibco) and resuspended in N2 media (4×104 cells/200μl). 
Subsequently, cells were attached on silane coating slide glass (Mutoglass, Japan) by use 
of cytospin (Shandon). Cells were fixed with 95% EtOH, washed, incubated for 10 
minutes with 5% potassium ferrocyanide in 1N hydrochloric acid, washed again, and 
counterstained with nuclear fast red for 1 minute.21 Images were obtained using 
fluorescence microscopy (Olympus, Tokyo, Japan) 
Internalization of the nanoparticle was visualized with electron microscopy using 
standard protocols.22 Cells were trypsinized and fixed with 2% glutaraldehyde + 2% 
paraformaldehyde in 0.1 M phosphate buffered saline at 4℃, 24hours. Sampling was 
processed with standard electron microscopy procedures and examined with a JEOL 
JEM-1011 transmission electron microscope (Jeol, Japan). 
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Zn ion level was measured by use of FluoZinTM-3, AM (Invitrogen, Waltham, MA, 
USA). FluoZinTM-3, AM dissolved in DMSO (Sigma), were mixed with 1:1 with Pluronic 
acid (Sigma, 20% in DMSO) to improve dispersion in the aqueous media.23-25 Mixture of 
Zn ion indicators were added to cell culture media 1 hour and were fixed by 4% PFA. 
Images were obtained using fluorescence microscopy (Olympus) and fluorescence level 
was measured by flow cytometry (Dickson). For positive control groups, NSCs were 
treated to 0.5ηM ZnCl2 1 hour. 
 
5. Magnet guided cell delivery in vitro and in vivo 
 
0.2% agarose gel (weight/volume) was used to develop a robust model of 
intraparenchymal brain tissue for the purpose of simulating cell migration in brain 
tissue.26,27 This brain mimicking in vitro model consisted of two different compartments; 
one was agarose gel which is known to similar density with brain tissue, the other was 
capillary tube containing phosphate buffered salilne (PBS) which mimics the blood vessel 
environment. For visualization of the cell migration, we used Lenti-Fluc-GFP-NSCs. 3 
group of cells (ZnMNP-Lenti-Fluc-GFP-NSCs, FeMNP-Lenti-Fluc-GFP-NSCs and 
Lenti-Fluc-GFP-NSCs) were loaded to the capillary tube and exposed to the magnetic 
field. After applying magnetic field for 12 hours, luciferase activity was visualized every 
2-3 hours. 
  In vivo magnetic cell guidance experiment was performed using adult male Sprague-
Dawley (SD) rats weighing 250±10g. This animal experiment was performed in strict 
accordance with the recommendation in the Guide for the Care and Use of Laboratory 
Animals of the National Institute of Health. Also the protocol was approved by the 
committee in the Ethics of Animal experiments of Yonsei University College of Medicine 
(Permission number, 2013-0135). All animals were purchased from the same commercial 
breeder (Orient, Korea) and were housed in the same specific pathogen free (SPF) facility 
under a 12 hours light/dark cycle with ad libitum feeding. Lenti-Fluc-GFP-ZnMNP-NSCs 
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were transplanted into the rat brains. Animals were anaesthetized with 2.5% isoflurane 
(Hanapharma, Busan, Korea) with oxygen and the skull was exposed. Total number of 
1.2×105 cells in 4μl was transplanted using a hamilton syringe (Hamilton Com., NV, 
USA), into the right corpus callosum at the following stereotaxic coordinates in 
millimeters (AP 0 mm, ML 0.5 mm, and DV 4.0 mm from the bregma). Unlike other 
usual experiment using stereotaxic frame, we did not use vertical injection to avoid the 
rough leaking of transplanted cells. Instead, injections needles entered obliquely at 45 
degree by use of trigonometrical calculation. The injection rate was 1μl/min and the 
hamilton syringe was left in place for 5 minutes before retraction. 24 hours after 
transplantation, neodymium (10mm diameter) was implanted above the skull bregma.  
 
6. Cytotoxicity of Zn-doped magnetic nanoparticle 
 
Cell viability was assessed using Cell Counting kit-8 (CCK8; Dojingo Molecular 
Technologies, Inc, Rockville, MD, USA) containing WST-8 (2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt), 
which is reduced by dehydrogenases in cells to give a yellow-colored product, formazan. 
The amount of the formazan dye generated by the activity of dehydrogenases in cells is 
directly proportional to the number of living cells, thus allowing estimation of the number 
of viable cells in the medium by absorbance at 450nm. 
Cytotoxicity was assessed immunostaining of active caspase-328 and transferase 
dUTP nick and labeling (TUNEL) staining29 in vitro to confirm cytoxicity at 3 days after 
transfection. Cells were treated with 0.05% T/E (Gibco) and resuspended in N2 media. 
Subsequently, cells were attached on saline coating slide glass (Mutoglass) by use of 
cytospin (Shandon) and performed immunocytochemistry with the rabbit anti-caspase 3 
antibody (Table. 1). The secondary antibody used were FITC-conjugated anti-rabbit-IgG. 
TUNEL assay was performed using In Situ Cell Detection kit (Roche Applied Science, 
Indianapolis, IN, USA). Cells were fixed with 4% paraformaldehyde (PFA) in PBS for 1 
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hour at room temperature. The samples were washed with PBS and then permeabilized by 
0.1% Triton X-100 in 0.1% sodium citrate buffer for 15 minutes at 4℃. After 3 times 
washing, cells were treated with TUNEL reaction mixture (Roche Applied Science) and 
incubated for 60 minutes at 37℃. Images were obtained using fluorescence microscopy 
(Olympus). 
Reactive oxygen species (ROS) was measured using 6-carboxy-2`,7`-
dichlorodihydrofluorescein diacetate (DCFH-DA, Sigma).30 Briefly, cells  were seeded 
onto 96-well black plates at a density of 5,000 cells/well. 24 hours after seeding, cells 
were washed with PBS, treated with 100μM DCFH-DA in cell culture media for 1 hour. 
Cells were then washed with PBS again and lysate with Tissue Protein Extraction 
Reagent (T-PER; Thermo Fisher Scientific). ROS level was measured by luminescence 
spectrometer LS50B (Perkin Elmer Akron, OH, USA) and normalized to protein 
concentrations, For positive control groups, NSCs were exposed to ultraviolet (UV) 20 
minutes. 
  Next, we measured DNA damage by use of comet assay, based on gel 
electrophoresis method.31 Slide glass were coated with mixture of low melting agarose 
solution (Sigma) and trypsinized cell. Coated slide glasses were treated by 0.5M 
Na2EDTA (pH8.0) solution for 24 hours at 4°C, and conducted electrophoresis for 25 
minutes at a voltage of 0.6V/cm. Subsequently, slide samples were treated with Dapi 
(Vector). Images were obtained using fluorescence microscopy (Olympus). 
 
7. Measurement of proliferation 
 
NSCs proliferation was determined by quantifying DNA replication using 
Bromodeoxyuridine (5-bromo-2'-deoxyuridine, reffered to BrdU), a thymidine analogue, 
which enables the detection of actively proliferating cells that have progressed in S 
phase.32 Cells were seeded onto 6 well culture dishes at approximately 1X106 cells/well 
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without mitogen for 24 hours to stop the cell cycles. Cells were next incubated with BrdU 
at a final concentration of 2μM for 3 days and were fixed with a 100% ethanol. After cell 
membrane permeabilization using 2N hydrochloric acid (HCl), the cells were labeled 
with a fluorescein (FITC) conjugated anti-BrdU antibody (Sigma). Cells were counted by 
flow cytometry (Dickson). 
 
8. Reverse transcription-polymerase chain reaction 
 
Total Ribonucleic acid (RNA) was prepared from cell using TRI Reagent® 
(Molecular Research Center, Inc, Cincinnati, OH, USA). RNAs were quantified 
spectrophotometrically, and then 5μg of isolated RNA was reverse transcribed using 
SuperscriptTMIII Reverse Transcriptase (Invitrogen) in 20μl reaction volume for 
complementary deoxyribonucleic acid (cDNA) synthesis. Therefore, 1μl cDNA was used 
for polymerase chain reaction (PCR) in 20μl volume. Primer pairs were designed and 
customized to detect target gene (Table. 2). PCR products were confirmed with 1.5% 
agarose gel electrophoresis and staining of ethidium bromide (EtBr, Sigma). 
 
9. Fate confirmation of Zn-doped magnetic nanoparticle-neural stem cells by 
immunocytochemistry 
 
Trypsinized NSCs were dissociated into a single cell suspension and directly plated 
onto PLL (10μg/ml, Sigma) in DMEM/F-12 that contained N2 supplement without any 
mitogens. The cells were fixed on 7 days with 4% PFA for 20 minutes, rinsed three 
times with PBS, and immunostained with lineage specific antibodies (Table. 1 ; Nestin, 
GFAP, Tuj1).19 Following rinsing with PBS, the slides were incubated with species 
specific secondary antibodies conjugated with FITC or Texas Red (Vector). Dapi was 
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used as the nuclear staining. Images were obtained using fluorescence microscopy 
(Olympus). 
10. β-catenin nuclear trans-location 
 
To evaluate the level of β-catenin expressed in the cell nucleus, we plated trypsinized 
single cells on PLL-coated 8 well chamber slides and immunostained with antibody 
againist β-catenin (Table. 1). Images were obtained using fluorescence microscopy 
(Olympus). We quantified the intensities of the piexels in each channel (Dapi; blue, β-
catenin; green) in the sections and generated histogram by use of photoshop CS3 software 
(Adobe systems, San Jose, CA, USA). The levels of β-catenin were deternmined and 
mean values calculated within the cell nucleus (Dapi).33 
 
11. Reporter assay  
 
Cells were transfected with reporter plasmids (TCF/LEF promoter following Firefly 
luciferase containing plasmid and CMV promoter following Renilla luciferase containing 
plasmid; 40:1) by Attractene Transfection Reagent 301004 (Qiagen, Valencia, CA, USA). 
We measured luciferase acitivity 120 hours after transfection in 50μl of lysis 
supernatant with the Cignal Reporter Assay system (Qiagen). The Firefly luminescence 
signal was quantified with a luminometer (Berthold, Wilbad, Germany) and normalized 
by Renilla luminescence signal.34 This analysis were conducted not just neural stem cells, 
but MDA-MB-231 cells (breast cancer cell line) and HEK 293 cells (human embryonic 
kidney cell line). 
 
12.  Western Blot analysis 
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Protein samples were prepared in two different types; cell lysate and cell culture 
conditioned medium. Cell lysate samples were prepared using homogenization in Tissue 
Protein Extraction Reagent (T-PER; Thermo Fisher Scientific, Suwanee, GA) 
supplemented with protease inhibitors (Sigma). Cell culture conditioned medium was 
concentrated 10-fold using Amicon Ultra-0.5 centrifugal filter device (Millipore, 
Darmstadt, German). Both protein samples were resolved by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Samples were loaded onto 10% tris-
glycine gels, and the proteins were transferred from the gel onto a 0.45μm nitrocellulose 
membrane (Thermo Scientific) over 4 hours at 4℃. The protein blots were blocked with 
5% skimmed milf in TBST and incubated with 0.25 bovine serum albumin in tirs-
buffered saline and tween 20 (TBST) overnight at 4℃ with the primary antibodies 
(Table. 3). Then, protein included membranes were rinsed with TBST, incubated with a 
horseradish peroxidase-conjugated secondary antibodies, for 1 hour at room temperature, 
and developed using SuperSignal West Pico Chemiluminescent substrate (Thermo 
Scientific).35 The images were scanned with a Fujifilm LAS-4000 mini-imager and band 
densities were measured by ImageJ software (http://imagej.nih.gov/ij/). In cell lysate 
samples, band densities were normalized by the density of β-actin. In cell culture 
medium samples, band densities were normalized by the density of the 75 kDa ponceau 
red staining band. 
 
13. Quantitative real-time reverse transcription-polymerase chain reaction 
 
Total RNA was prepared from cell using TRI Reagent (Molecular Research Center), 
and 2μg of RNA was reverse-transcribed into cDNA using random hexamer primers 
(Bioneer, Daejeon, Korea) and Supercript III reverse transcriptase (Invitrogen) in a 
thermal cycler (Eppendorf, Happauge, NY, USA). Quantitative RT-PCR was carried out 
in a total volume of 10μl containing 5μl of LightCycler® 480SYBRGreen I Master (Roche 
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Diagnostics Ltd., Rotkreuz, Switzerland), 0.5μM of each primer and 2.5μl of 1:10 diluted 
cDNA using LightCycler®480 instrument (Roche Diagnostics Ltd). The cycling conditions  
Table 2. Sequences of primers used for RT-PCR 
 
Gene Gene Bank ID1 Primers (5`→3`)2 
Wnt1 NM_005430.3 
5`-CGGCGTTTATCTTCGCTATCA-3` 
5`-GCAGGATTCGATGGAACCTTCT-3` 
Wnt3a NM_033131 
5`-AGCTACCCGATCTGGTGGTC-3` 
5`-CAAACTCGATGTCCTCGCTAC-3` 
Nestin NM_006617 
5`-TGGAGTCTGTGGAAGTGAACC-3` 
5`-CATTTTCCACTCCAGCCATCC-3` 
Sox2 NM_181701 
5`-CTCGTGCAGTTCTACTCGTCG-3` 
5`-AGCTCTCGGTCAGGTCCTTT-3` 
Neurog2 NM_024091 
5`-CGAAACCGCATGCACAACCTC-3` 
5`-TGGAATTGGAGGACACGGAGG-3` 
NeuroD1 NM_002500 
5`-GCTGCCCAGTCCGCCTTACG-3` 
5`-CTCGGCGGACGGTTCGTGTT-3` 
ASCL1 NM_034316 
5`-GGCTCAACTTCAGCGGCTT-3` 
5`-CAGTGTCTCCACCTTACTCATCT-3` 
Tuj1 NM_006086 
5`-CCGAGCTCACCCAGCAGATGT-3` 
5`-AACATGGCCGTGAACTGCTCG-3` 
SGC10 S82024.1 
5`-CATCAACATCTATACTTACG-3` 
5`-GCCAATTGTTTCAGCACCTG-3` 
Tbr2 AB_031038.1 
5`-ACATTGCTCCCATATGGCATT-3` 
5`-CCTTCGCTTACAAGCACTGGT-3` 
GAD65 NM_001134366 
5`-TTTTGGTCTTTCGGGTCGGAA-3` 
5`-TTCTCGGCGTCTCCGTAGAG-3` 
s100b NM_006272 
5`-GGTGGCCCTCATCGACGTTTT-3` 
5`-TCGCCGTCTCCATCATTGTCC-3` 
BLBP NM_001446.3 
5`-TACATGAAGGCTCTAGGCGTG-3` 
5`-CCACATCACCAAAAGTAAGGG-3` 
GS NM_001033056.3 
5`-GAGGCACACCTGTAAACGGA-3` 
5`-ATAGGCTCTGTCTGCTCCCA-3` 
NG2 NM_012283 
5`-ACTTTGCCACTGAGCCTTACA-3` 
5`-GTTTTCGGAGGTAGAAGAGCAG-3` 
Olig2 NM_005806 
5`-AGGACAAGAAGCAAATGACAGAG-3` 
5`-AGTTGGTGAGCATGAGGATGTAGT-3` 
GAPDH NM_001256799 
5`-ACCACAGTCCATGCCATCAC-3` 
5`-TCCACCACCCTGTTGCTGTA-3` 
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1  Query Genetic code of NCBI database (www. ncbi.nlm,nih/gov/pubmed) 
2  Primer sequences were obtained from the NCBI database and customized by Bioneer 
(Daejeon, Korea). 
Table 3. Antibodies used for western blotting 
 
Antibodies Host Size1 Titer Company Domicilli 
Wnt1 rabbit 41 1:1000 Santacruz Dallas, TX, USA 
Wnt3a Rat 40 1:1000 R&D Mineapolis, MN, USA 
NTF3 rabbit 35 1:1000 
Santacruz Dallas, TX, USA 
NTF4 rabbit 14 1:1000 
NGF rabbit 13 1:1000 
Cell 
signaling Danvers, MA, USA β-catenin rabbit 92 1:1000 
Map2 rabbit 250 1:1000 
Tuj1 mouse 50 1:5000 Covance Princeton, NJ, USA 
β-actin mouse 42 1:1000 Sigma St.Louis, MO, USA 
 
1  Size of the target protein. Unit is kDa. 
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were: 95°C for 5 minutes, followed by 45 cycles of 95°C for 10 seconds, and 72°C for 10 
seconds. All the samples were carried out in triplicates. The expression level of each 
mRNA expression were normalized to the housekeeping gene GAPDH using 
LightCycler®480 software, Version 1.5 (Roche Diagnostics Ltd).36  Primer sequences 
for target genes were listed in Table. 4.  
  
14.  Immunohistochemistry 
 
Animals were deeply anesthetized with ketamine (75mg/kg, i.p.) and xylazine 
(30mg/kg, i.p.) and were trascardially perfused with cold PBS followed by cold 4% PFA. 
Brains were then removed, post fixed, transferred in 30% sucrose in PBS for 
cryoprotection and frozen in O.C.T compound (Sakura Finetek, Torrance, CA, USA). 
Frozen samples were coronally sliced into 30 μm sections using a cryostat. 
For fluorescence immunohistochemistry, sections were washed in PBS and blocked with 
3% bovine serum albumin (Sigma), 10% normal horse serum (Sigma), and 0.3% Triton 
X-100 (Sigma) in PBS. Sections were incubated with following primary antibodies; anti-
human nucleus with anti-nestin or anti-neuronal class β-tublin III (Tuj1) or anti-Map2 or 
anti-DCX or anti-GFAP or anti-PDGFα (Table. 1). Images were obtained using Zeiss 
LSM 700 confocal microscope (Carl Zeiss, Oberkochen, Germany). 
For immuneperoxidase staining, section were incubated with 0.3% H2O2 in methanol 
for blocking endogenous peroxidase activity. Sections were incubated with anti-human 
specific cytoplasm SC121 (Table. 1), and were developed with diaminobenzidine (DAB; 
Sigma) substrate using VECORSTAIN Elite ABC kit (Vector laboratories). After the 
DAB reaction, samples were additionally stained for Perl`s prussian blue staining and 
nuclear fast red. 
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15.  Middle Cerebral Artery Occlusion animal model 
 
 Adult male Sprague-Dawley (SD) rats weighing 250±10g were used. Ethical guidelines, 
purchasing and housing were the same as above method (5. Magnetic guided cell 
delivery). During the whole procedure, each animal was anaesthetized with 2.5% 
isoflurane (Hana pharm, Busan, Korea) with oxygen and body temperature was 
maintained 37.0±0.5℃ with a warm pad. Through a midline neck incision, right carotid 
bifurcation of rat was exposed within the carotid muscular triagle.37-40 Through a right 
carotid bifurcation, a sterile 3-0 nylon suture (AILEE Co, Busan, Korea) was introduced 
into the right internal carotid artery at a distance of 20.0±0.5mm from the carotid 
bifurcation to occlude the origin of middle cerebral artery.37-41 After a lapse of 30 minutes, 
intraluminal nylon filament was carefully removed and incision was sutured. Immediately 
after occlusion, neodymium magnet (10mm diameter) was implanted above the skull 
bregma. Surgical procedure is summarized in Figure 1.  
 
16.  Blood Brain Barrier Disruption 
 
BBB disruption was examined by injecting evans blue (Sigma) to femoral vein (0.05% 
Evans blue in PBS, 1ml/kg) of MCAO animal.40 After a lapse of 4 hours, transcardiac 
perfusion with PBS slowly and brain was dissected from the skull and stained with 4% 
triphenyl tetrazolium chloride (TTC, Sigma) 30min, 37℃. Images were obtained using 
commercial digital camera.  
 
17.  Intra-arterial cell injection 
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  24 hours after occlusion, right carotid bifucation was re-exposed, and ZnMNP-NSCs 
(3×106 cells/100㎕) were injected slowly (25㎕/min) through carotid artery by use of 
polyethylene tube (Jeungdo, Seoul, Korea).42,43 
 
 
Figure 1. Middle cerebral artery occlusion animal model. Temporally blocking of 
middle cerebral artery imitate 80% of human brain stroke cases. As brain energy 
dependent processes fail, neurons are unable to maintain their normal transmembrane 
ionic gradients, resulting in an ion and water imbalance that leads to apoptotic and 
necrotic cell death cascades and ultimately the impairment of sensory and motor function. 
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18.  Magnetic Resonance Imaging (MRI) 
 
Both in vitro and in vivo MRI were performed by use of clinical 3.0 T MRI scanner 
(Achieva XT, Philips, Netherland) with animal coil (Shanghai Chenguang, China). 
Implanted neodymium was removed before scanning based on safety regulations of MRI. 
During the scanning, animals were anaesthetized with 2.5% isoflurane (Hana pharm) with 
oxygen. The T2 weighted images were obtained using in a fast spin echo sequence 
(TR/TE 4000 /80ms, field of view 50mm, matrix 256×256, slice thickness 0.5mm, 
acquistion number 1).18,44 
   The cerebral infarct volume in each brain were estimated using MRI. In T2-weighted 
images, infarction area reveal bright signal compared to intact area. MR images were 
obtained after cell injection 1-day, 1-week, 3-week. The results are expressed as 
percentage of infarct area compared with contralateral hemisphere area, considering that 
as 100%.45 
 
19.  Bioluminescence Imaging (BLI) 
 
Some MCAO animals were transplanted ZnMNP-lenti-Fluc-GFP-NSCs with same 
condition.18,46 Rats were given an intraperitoneal injection of D-luciferin (150mg/kg, 
Progema, WI, USA). Animals were anaesthetized during the scan with 2.5% isoflurane 
(Hana pharm) with oxygen. BLI signal was recorded as maximum photon flux by IVIS 
spectrum in vivo preclinical imaging system (Perkin Elmer).18,46 Living image 3.0 
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software (Perkin Elmer) was used to quantifying in the head.  
 
 
Table 4. Sequences of primers used for Quantitative RT-PCR 
 
Gene Gene Bank ID1 Primers (5`→3`)2 
Nestin NM_006617 
5’-GGCGCACCTCAAGATGTCC-3’  
5’-CTTGGGGTCCTGAAAGGCTG-3’ 
GFAP NM_001242376 
5’-CTTCTCCAACCTGCAGATTCG-3’  
5’-CACGGTCTTCACCACGATGTT-3’ 
TUJ1 NM_006086 
5’-GGCCAAGGGTCACTACACG-3’  
5’-GCAGTCGCAGTTTTCACACTC-3’ 
GALC NM_001201401 
5`-TCTCTGGGAGTCCATCTCTGC-3` 
5`-CTACCACGTAGTGCCCACTCC-3` 
ZIC1 NM_003403 
5`-TGGCCCGGAGCAGAGTAAT-3’  
5`-CCCTGTGTGCGTCCTTTTG-3’  
ZIC2 NM_007129 
5`-CACCTCCGATAAGCCCTATCT-3’  
5`-GGCGTGGACGACTCATAGC-3’  
AXIN2 NM_004655 
5`-TACACTCCTTATTGGGCGATCA-3’  
5’-TTGGCTACTCGTAAAGTTTT-3’ 
Neurog2 NM_024091 
5’-CGCATCAAGAAGACCCGTAG-3’  
5’-GTGAGTGCCCAGATGAGTTGTG-3’ 
NEUROD1 NM_002500 
5’-ACCAAATCGTACAGCGAGAGT-3’  
5’-CTCGTCCTGAGAACTGAGACA-3’ 
GAPDH NM_001256799 
5’-CCATGAGAAGTATGACAACAGCC-3’  
5’-GGGTGCTAAGCAGTTGGTG-3’ 
 
1   Query Genetic code of NCBI database (www. ncbi.nlm,nih/gov/pubmed). 
2 Primer sequences were obtained from the Primer bank database 
(http://pga.mgh.harvard.edu/primerbank/) and customized by Bioneer (Daejeon, Korea). 
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20.  Assymeteric cylinder neurological test 
 
   All animals underwent behavioral tests before MCAO and 1, 7, 21 days after 
transplantation. This test was used to evaluate locomotor asymmetry.47,48 As the animal 
moved within an open-top, clear plastic cylinder (diameter 200 mm, height 300 mm) in 
front of 2 mirrors those are arranged as right angles. Forelimb activity while rearing 
againist the wall of the cylinder is recorded for 10 minutes. The results were expressed as 
percentage of impaired forelimb activity compared with total forelimb activity. 
 
21.  Statistical analysis 
 
   The statistic software SPSS18.0 (SPSS Inc., Chicago, IL, USA) was used for data 
analysis. Values were reported as mean±SEM. Statistical differences were assessed either 
by a non-parametric Mann-Whitney U test and a non-parametric one-way Kruskal-Wallis 
test. A value of p<0.05 was chosen for statistical significance. 
 
22. Code of ethics and law 
 
   All in vitro experiments were conducted in level 2 LMO (living modified organism) 
facility. Quantitative real-time reverse transcription-polymerase chain reaction was 
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followed according to the MIQE (minimum information for publication of quantitative 
real-time PCR experiments) guideline. All animal experiments were conducted in SPF 
(specific pathogen free) facility received full accreditation by AAALAC international 
and complying the previous ethical guideline. The ARRIVE (animal research : reporting 
in vivo experiments) guideline was considered in the design and report of the study.  
III. RESULTS 
 
1. Human neural stem cells form self-renewing neurospheres and have 
multipotency 
     
Proliferating single cells from the telencephalon of human fetus at 13 weeks of 
gestation (termed NSCs) give rise to free-floating spheres called neurospheres; These 
were identified by their phase-bright appearance (Fig. 2 a).19 To analyze the cellular 
composition of the neurosphere, we investigated the expression of lineage specific 
markers. Most of neurosphere forming cells (95-99%) express Pax6, Nestin, Sox2, 
CD133, PCNA, KI67, GFAP, vimentin (Fig. 2 b-e) known as immature markers. Some 
cells that strongly expressed Tuj1 were predominantly found in the sphere core (Fig. 2 f). 
Also, neurosphere forming cells express and secrete several neurotrophic factors such as 
neurotrophin-3 (NTF3; Fig. 2 g), neurotrophin-4 (NTF4; Fig. 2 i), brain-derived 
neurotrophic factor (BDNF; Fig. 2 j), nerve growth factor (NGF; Fig. 2 h), glial-derived 
neurotrophic factor (GDNF; Fig. 2 k), vascular endothelial growth factor (VEGF; Fig. 2 l), 
fibroblast growth factor (FGF; Fig. 2 m). When plated on PLL coated dished without 
mitogen, NSCs expressed Tuj1 as an early neuron marker (Fig. 2 o), glutamate as a 
glutamergic interneuron marker (Fig. 2 p), Calrectinin as a GABaergic interneuron 
marker (Fig. 2 q), TH as a dopaminergic neuron (Fig. 2 r). GFAP and S100-β as astroglial 
markers (Fig. 2 s,t), MBP and O4 as oligodendrocytic markers (Fig. 2 u,v). These data 
confirm that our NSCs are capable of self-renewing and multipotent under differentiation 
conditions.49-51 
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2.  Firefly luciferase expressing neural stem cells 
 
NSCs were exposed to lentiviral particle including Fluc gene and reporter gene GFP 
 
 
Figure 2. Neural stem cell characterization. (a-m), Neuroshpere formation by 
proliferating neural stem cells. Phase microscopy (a) and immune fluorescence labeling 
(b-m) of representative telencephalic neurosphere grown in bFGF and LIF. Neurospheres 
were stained for Pax6 (b), Nestin with Sox2 (c), CD133 with PCNA (d), GFAP with 
Vimentin (e), Tuj1 (f), NTF3 (g), NGF (h), NTF4 (i), BDNF (j), GDNF (k), VEGF (l), 
FGF (m). Under differentiation conditions, neural stem cells differentiated into multiple 
lineages. Phase microscopy (n), neuronal markers (o-r) and astroglial markers GFAP (s) 
and S100-β (t) were shown. A few cells expressed oligodendrocyte markers MBP (u) and 
O4 (v). 
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(Fig. 3 a). Fluc gene expressing cells produced near-infrared photon signaling in the 
presence of D-luciferin (Fig. 3 bi, bii). Only GFP not Fluc expressing cells were not 
produce signal (Fig. 3 biii). Flow cytometry confirmed that 93.1% of NSCs expressed 
foreign gene (Fig. 3 d). Lentiviral Fluc expressing NSCs (Lt-Fluc-NSCs) formed 
neurosphere as well as original NSCs (Fig. 3 d). The Fluc activity continuously increased 
in NSCs in proportion to cell number (Fig. 3 e). Using these characteristics, Lt-Fluc-
NSCs were used to visualize the cellular location and to measure of the number of cells. 
 
3.  Zn-doped magnetic nanoparticle properties and intracellular labeling 
 
ZnMNP was designed into three multiple layers (Fig. 4 a). Central core was the source 
of strong magnetic properties. Inner layer was dextran for biocompatibility, surface layer 
was PLL for cell transfection. Due to the three-layer structure, ZnMNP had high magnetic 
saturation magnetization (161 emu/g; Fig. 4 b), equally contributed in circular form of 
18nm diameter scale (Fig. 4 c, d) and easily transfected to NSCs. In Prussian blue 
staining, more than 95% cells showed cytosolic nanoparticles (Fig. 4 e, f). Inductively 
Coupled Plasma (ICP) analysis revealed that 4.58±0.94 pg of ZnMNP was internalized in 
single neural stem cells. In electron microscope image, cytosolic nanoparticles were 
settled in endosomal vesicles (Fig. 4 g, h). Ferumoxide (FeMNP) often used to labeling 
cells52 but FeMNP had lower magnetization(105 emu/g; Fig. 4 b). FeMNP labled cells 
could be detected by MRI at least 50,000 cells per 1 mm3. By contrast, ZnMNP cells were 
detected in 1,000 cells per 1 mm3 (Fig. 4 i, j). 
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In order to examine whether the ZnMNPs were decomposed inside the NSCs, 
fluorscnece zinc ion indicator (Fig. 5 a) was used. Both flow cytometry (Fig. 5 b) and 
fluorescence images (Fig. 5 c) showed no difference. These data suggest that NSCs were 
not exposed to over concentration of Zn ion.  
 
 
 
Figure 3. Firefly Luciferase and GFP expressing NSCs. (a), Recombinant lentiviral 
vector containing Fluc and GFP. (b), Fluc and GFP expressing NSCs produced near-
infrared signaling in the presence of D-luciferin (bi). In the absence of D-luciferin, signal 
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was not detected (bii). Only GFP expressing cells, signal was not detected in the presence 
or absence of D-luciferin (biii). (d), 93.1% of total cells express Fluc and GFP in flow 
cytometry. Fluc and GFP expressing cells formed neurosphere as well as non-transfected 
NSCs. (e), Fluc activating signal was directly proportional to stem cell number. 
 
 
4.  Magnetotactic ability of Zn-doped magnetic nanoparticle-neural stem 
cells 
 
The attraction force (𝐹𝑚) of ZnMNPs, which serves as an engine of the ZnMNP-NSCs, 
depends on the magnetic gradient field of magnet ( , where 𝑉 is 
volume of MNP; 𝑀 is magnetization value of MNP; 𝐵 is magnetic gradient field).53 
According to the simulation study (Fig. 6 a), the attraction force experienced by the single 
ZnMNP-NSC under the magnetic gradient field of typical NdFeB magnet was increased 
from 2 pN to 170 pN as the distance between the magnet and ZnMNP-NSCs is decreased 
from 1 cm to 0 cm. Considering the diameter of rat brain is less than 1 cm, entire rat brain 
can be exposed under adequate magnetic gradient field by placing the magnet on head. 
Thus, ZnMNP-NSCs transplanted to the rat brain are expected to have attraction force of 
pico-Newton range which is known to promote the displacement of the cells.54-57 To 
demonstrate the ability of the magnet-guided delivery of ZnMNP-NSCs, we choose rat 
brain as a model system. Prior to performing in vivo experiment, we first tested magnet-
guided delivery in a brain mimicking in vitro model (Fig. 6 a). This model consists of two 
different compartments; one is 0.2 % (wt/v) agarose gel which is known to have similar 
density with brain tissue,27 the other is capillary tube containing phosphate buffer saline 
(PBS) which mimics the blood vessel environment. For visualization of the cell migration, 
BMVFm )∇•(=
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NSCs were labeled with luciferase that can be detected using bioluminescence imaging 
(BLI). Three groups of cells (ZnMNP-NSCs, FeMNP-NSCs, and NSCs) were loaded to 
the capillary tube and exposed to the magnetic field (1.0 Tesla NdFeB magnet). After 
applying magnetic field for 12 hours, ZnMNP-NSCs migrated toward the magnet 
penetrating the agarose gel. In the case of FeMNP-NSCs, cells migrated toward the 
magnet but they did not penetrate the gel. Non-labeled NSCs were somewhat diffused in 
 
 
Figure 4. Zn-doped magnetic nanoparticle and intracellular labeling. (a), Tri-layer 
structure of ZnMNP. (b), Magnetic power of ZnMNP compared to commercial particle. (c, 
d), Transmission electron microscope image of ZnMNP. (e, f), Perl`s prussian blue 
staining with nuclear fast red counter staining of ZnMNP labeled NSCs. (g, h), 
Transmission electron microscope image of ZnMNP labeled NSCs. (i, j), In vitro 
phantom MR image of commercial particle and ZnMNP labeled NSCs.  
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Figure 5. Zinc ion staining. (a), Chemical structure of Zinc ion indicating fluorescence 
dye. For the positive control, 0.5nM ZnCl2 was treated. NSCs, FeMNP-NSCs and 
ZnMNP-NSCs shows no difference in flow cytometry (b) and microscopic observations 
(c-f). 
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the capillary but did not reach to agarose gel region (Fig. 6 c). These results indicate that 
only ZnMNP-NSCs possess sufficient magnetic attraction force for magnet-guided 
delivery in rat brain. 
To gain further evidence for the magnetotaxy of ZnMNP-NSCs, in vivo magnetic 
guidance experiment was performed using rat. ZnMNP-NSCs were transplanted in 
subventricular zone (SVZ) of rat brain and magnetic gradient field was applied by 
attaching NdFeB magnet on the head of rat (Fig. 7 f). The location of the transplanted 
ZnMNP-NSCs was non-invasively monitored using magnetic resonance imaging (MRI) 
in the adult rat brain. In general, transplanted NSCs into the SVZ migrate toward the left 
olfactory bulb (OB) via a route called the rostral migratory stream (RMS), and along the 
corpus callosum (CC) and white matter tract (WM) in response to normal 
microenvironmental cues (Fig. 7 a-c).58 Using magnetic guidance, it is possible to change 
the migration route as desired. ZnMNP-NSCs were transplanted into SVZ of the adult rat 
brain and exposed to magnetic field for 7 days, cells migrated toward the magnet 
positioned at the upper region of the brain cortex (Fig. 7 d-g). The results clearly 
demonstrate that the migration of ZnMNP-NSCs can be effectively controlled using a 
magnet in an in vivo system. 
 
5.  Effects of Zn-doped magnetic nanoparticle in neural stem cell homeostasis 
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We studied the biocompatibility and effects of ZnMNP on NSCs. According to a 
dosage-dependent cell viability test, ZnMNP induce no toxic effects even at the high 
concentration of 1000 (Fe) μg/ml (Fig. 8 a) and after long-term exposure (Fig. 8 b). 
Additionally, there were no significant changes in both TUNEL staining (Fig. 8 c) and 
 
 
Figure 6. In vitro magnetotatic migration. (a), Brain mimicking in vitro model. 0.2% 
agarose gel which is known to have similar density with brain tissue. (b), The amount of 
the magnetic attraction force of single cell according to the distance from magnet. (c), 
Magnetic guided migration of NSCs, FeMNP-NSCs, ZnMNP-NSCs in brain mimicking 
in vitro system. 
 
『Abbreviation』 T; tesla. 
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Figure 7. In vivo magnetotactic migration. (a), Without magnetic field, cells migrated 
via rostral migratory stream (RMS, blue dots). (b,c), MR image and histological images 
showed migrating path of non-maget guided migration via RMS. (d), In a static magnetic 
field, cell migrating route was changed (red dots). (e), MR image showed altered 
migrating path. (f), Magnet attachment of animal skull bregma. (g), Histological images 
showed altered migrating path with the temporal scale of day1, day3, day5, day7. 
 
『Abbreviation』 w/o MF; without magnetic field, w MF; with magnetic field, LV; lateral 
ventricle, cc; corpus callosum, OB; olfactory bulb, RMS; rostral migratory stream, WM; 
white matter tract, Cx; cerebral cortex, V; Ventricle, D; days post transplantation 
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active-caspase3 immunocytochemistry (Fig. 8 d). These data suggest that there were 
no toxic effect of ZnMNP on NSCs. 
Caveat may arise of oxygen free radical production or genotoxicity. However, there 
were no significant difference of reactive oxygen species level (Fig. 9 b) and showed no 
DNA disruption (Fig. 9 c-f) 
There were no changes in neurosphere morphology such as marker expression (Fig. 9 
a-c), neurosphere number (Fig. 10 d), NSCs number (Fig. 10 e), NSCs number per single 
neurosphere (Fig. 10 f), neurosphere diameter (Fig. 10 g). 
To the next, we analyzed the proliferation of ZnMNP-NSCs compared with NSCs and 
FeMNP-NSCs. Pre-treated 2μM BrdU was immunelabeled and counted by flow-
cytometry (Fig. 11 b) and observed by microscope (Fig. 11 c-e). There were no 
significant changes in the proliferation. 
 
6.  Neuronal differentiation of ZnMNP-NSCs 
 
In genetic screening by use of PCR, gene expression pattern was changed. Basic helix 
loop helix (bHLH) proneural transcription factors (NEUROGENIN-2, NEUROD1, ASCL1) 
and neuronal gene (TUJ1, SCG10, TBR2) were increased in ZnMNP-NSCs compared to 
control groups (Fig. 12 a). Similarly, the differentiation patterns of ZnMNP-NSCs were 
significantly different from those of unlabeled NSCs and FeMNP-NSCs. In the case of 
the ZnMNP-NSCs, neuronal differentiation was markedly increased under the 
differentiation condition. The percentage of neuronal marker Tuj1 positive cells in 
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ZnMNP-NSCs were significantly increased compared to NSCs and FeMNP-NSCs in 
vitro (Fig. 12 j-l,n, Table. 5) while neural stem cell marker nestin and glial marker GFAP 
were decreased (Fig. 12 b-d, f-h, n, Table. 5). Additionally, the treatment of Wnt signal 
 
 
Figure 8. Zn-doped magnetic nanoparticle mediated apoptosis. (a), Mitochondrial 
function of NSCs according to the ZnMNP concentrations. No significant changes among 
three groups. (b), Mitochondrial function of long term exposure of ZnMNP to NSCs. No 
significant changes between two groups. (c-j), TUNEL staining and active caspase-3 
immuno cytochemistry shows no difference among three groups. All data were expressed 
as mean±Standard error of the mean (SEM). 
 
『Abbreviation』 TUNEL; terminal deoxynucleotidyl transferase dUTP nick and labeling 
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Figure 9. Zn-doped magnetic nanoparticle mediated genotoxicity. (a), Chemical 
structure of ROS indicating dye. (b), ROS level shows no difference among three groups. 
For the positive controls, NSCs were exposed ultraviolet 20 minutes and ROS level was 
enormously increased. (c-f), Comet assay to determine the genotoxicity. Comet tail seems 
to occur if the genomic DNA was fragmented. UV-exposed NSCs showed typical 
fragmented genomic DNA in Dapi staining (f). All three groups showed no genotoxicity. 
All data were expressed as mean±SEM. 
 
『Abbreviation』 ROS; reactive oxygen species, UV; ultra-violet 
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Figure 10. Neurosphere assay. (a), Non–labeled neural stem cells formed neurosphere. 
(b), FeMNP-labeled neural stem cell formed neurosphere. (c), ZnMNP-labeled neural 
stem cell formed neurosphere. (d-g), Neurosphere morphologies. All data were expressed 
as mean±SEM. 
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Figure 11. BrdU proliferation assay. (a), Chemical structure of BrdU. (b), Flow 
cytometry of BrdU positive cells. No significant changes among three groups. (c-e), 
Immunocytochemistry of BrdU-proliferating cells. 
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blockade Dikkopf1 (DKK1) into ZnMNP-NSCs (ZnMNP-NSCs-DKK1) reduced the 
effect of ZnMNP on prompoting neurogenesis and repressing gliogenesis of NSCs (Fig. 
12 e,i,m,n, Table. 5), which strongly suggest that the Wnt signaling is involved in the 
neuronal differentiation of ZnMNP-NSCs 
In order to ensure the involvement of Wnt signaling pathway, we tracked cellular 
location of β-catenin. Immunohistochemistry againist β-catenin shows translocation of β-
catenin in the presence of ZnMNP (Fig. 13 e-h). Non-labeled NSCs`s β-catenin were 
located in cytoplasm attached to the cell nucleus (Fig. 13 a-d). Also, Reporter assay was 
conducted. ZnMNP labeled cells were showed increased TCF/LEF promoter activation 
(Fig. 13 i-j). TCF/LEF promoter was activated when Wnt signaling mechanism was 
activated. 
Western blotting analysis and quantitative real time PCR (Q-PCR) analysis were 
conducted. Q-PCR analysis revealed zinc finger of the cerebellum1 (ZIC1) and zinc 
finger of the cerebellum2 (ZIC2) increment in ZnMNP-NSC in vitro (Fig. 14 c). 
Interestingly, ZIC transcription factors were increased whether DKK1 was present or not 
(Fig. 14 c). This data suggest that ZIC1, ZIC2 were located in the middle of the pathway; 
downstream of ZnMNP and upstream of wnt signaling pathway. In western blot analysis, 
Wnt ligands (Wnt1, Wnt3a) were increased both in cell culture media (Fig. 14 a) and cell 
lysate (Fig. 14 b). β-catenin, the key molecule of wnt signaling pathway, was less 
decomposed in ZnMNP-NSC compared to controls (Fig. 14 b). AXIN2, representative 
wnt signaling reporter gene which was measured by Q-PCR, was increased in ZnMNP-
NSc compared to controls (Fig. 14 c). Treating DKK1, both β-catenin and AXIN2 level 
were neutralized from ZnMNP`s influence (Fig. 14 b, c). Indeed, proneural bHLH 
transcription factors (NEUROGENIN-2, NEUROD1), neuronal gene (TUJ1), neuronal 
proteins (Tuj1, Map2) were increased in ZnMNP-NSCs and reduced by DKK1 (Fig. 14 
b,c). These data suggest that ZnMNP increases ZIC1, ZIC2 expression, then secrete wnt 
ligands (Wnt1, Wnt3a), continually activate canonical wnt signaling pathway resulting 
proneural bHLH transcription factor (NEUROGENIN-2, NEUROD1) increment.  
Ultimately, neuronal markers (TUJ1, Tuj1, Map2) increment appeared. Also, ZnMNP-
NSCs showed augmented of nerve growth factor (NGF), neurotrophin factor-3  (NTF3) 
secretion compared to controls (Fig. 14 a). Neural stem cell neurogenesis mediated by 
ZnMNP mechanism was summarized in the Fig. 15. Next, we confirmed that 
neurogenic phenomenon in vivo. We transplanted ZnMNP-NSCs (or controls; NSCs, 
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Figure 12. Genetic screening and differentiation patterns in vitro. (a), Traditional 
PCR analysis of ZnMNP-NSCs. Proneural bHLH transcription factors and neuronal 
genes were increased. (b-e), NSCs` marker Nestin expression of ZnMNP-NSCs and 
control groups. (f-i), Glial marker GFAP expression of ZnMNP-NSCs and control groups. 
(j-m), Neuronal marker Tuj1 expression of ZnMNP-NSCS and control groups. ZnMNP-
NSCs showed increased neuronal differentiation and decreased self renewing and glial 
differentiation. All changes were neutralized by DKK1 (b-n). All data were expressed as 
mean±SEM. *p<0.05 compared to NSCs, †p<0.05 compared to FeMNP-NSCs, §p<0.05 
compared to ZnMNP-NSCs-DKK1. 
 
『Abbreviation』  ASCL1; ,Neurog2; neurogenin2 
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Table 5. Differentiation pattern of Zn-doped magnetic nanoparticle-neural stem cells 
in vitro and in vivo 
 
  
NSCs 
 
(n=3) 
FeMNP-
NSCs 
(n=3) 
ZnMNP- 
NSCs 
(n=3) 
ZnMNP-
NSCs-DKK1 
(n=3) 
In vitro1 
Nestin 60.24±2.15 70.35±3.34 40.00±3.51*†§ 52.00±1.59 
GFAP 20.00±4.00 19.20±3.77 8.34±2.45*†§ 18.32±4.24 
TUJ1 60.24±4.24 61.23±6.42 90.36±5.32*†§ 50.18±4.21 
In vivo2 
Nestin 74.17±0.96 86.83±0.44 72.53±3.97 
 GFAP 49.78±9.83 60.20±8.90 48.67±10.17 
TUJ1 11.9±3.42 13.66±3.23 39.52±7.38*† 
 
1  In vitro experiments, data were expressed as a percentage of the Dapi-positive cells. 
2  In vivo experiments, data were expressed as a percentage of the hNuc-positive cells. 
All data were expressed as mean±SEM. *p<0.05 compared to NSCs, †p<0.05 compared 
to FeMNP-NSCs, §p<0.05 compared to ZnMNP-NSCs-DKK1. 
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Figure 13. Zn-doped magnetic nanoparticle mediated activation of Wnt signaling 
pathway. (a-h), Nuclear trans-location of β-catenin. NSCs exhibit cytosolic β-catenin (a-
d). By contrast, ZnMNP-NSCs showed nuclear positioned β-catenin (e-h). (i), Repoerter 
assay plasmid construction. TCF/LEF promoter is activated only in the activated Wnt 
signaling pathway cause expression of firefly luciferase. CMV promoter is housekeeping 
promoter. (j), MDA-MB-231 cells and HEK 293 cells exhibit ZnMNP mediated wnt 
signaling activation as with the neural stem cell. All data were expressed as mean±SEM 
(n=3). *Overlapping areas of β-catenin and Dapi, †p<0.05 compared to control. 
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Figure 14. Western blot analysis and Quantitative polymerase chain reaction 
analysis. (a), Relative levels of Wnt1, Wnt3a, NTF3, NGF using western blot analysis in 
cell culture medium of NSCs, FeMNP-NSCs, ZnMNP-NSCs, ZnMNP-NSCs-DKK1. (b), 
Relative levels of Wnt1, Wnt3a, β-catenin, Tuj1, MAP2 A/B using western blot analysis 
in the cell lysates. (c), The relative expression of mRNA for NESTIN, GFAP, TUJ1, 
GALC, ZIC1, ZIC2, AXIN2, NEUROG-2, NEUROD1. All data represent mean ± SEM 
(n=3), *p<0.05 compared to NSCs, †p<0.05 compared to FeMNP-NSCs, §p<0.05 
compared to ZnMNP-NSCs-DKK1. 
 
『Abbreviation』 Neurog2; neurogenin2 
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Figure 15. Mechanism of Zn-doped magnetic nanoparticle mediated neural stem cell 
neurogenesis. Foremost, ZIC1, ZIC2 transcription factors were increased. Like Xenopus 
system, ZIC transcription factors induce the secretion of Wnt1, Wnt3a ligands. Through 
the canonical wnt signaling pathway, β-catenin level was increased and translocated to 
cell nucleus. Wnt target genes, NEUROGENIN-2, NEUROD1 ,reponse to the signal and 
force neurogenesis to cells (Tuj1, MAP2 A/B). Furthermore, Neurotrophic factors (NTF3, 
NGF) were increased.  
 
 
 
44 
 
FeMNP-NSCs) into the subventricular zone. 1 week later, perl`s prussian blue staining 
(Fig. 16 a-c) and human nucleus immunostaining (Fig. 16 d-f) showed similar number of 
cells were settled in CC. But merged with neuronal marker Tuj1 clearly showed 
increased neurogenesis in vivo (Fig. 16 g-j,q-s, Table. 5). Other fate indicating markers 
(Nestin, GFAP, PDGFR) showed no signaficiant differences (Fig. 16 j-p, t-v, Table. 5). 
 
7.  Blood brain barrier disruption 
 
Evans blue dye was used to assess the permeability of the BBB. Because serum 
albumin cannot cross the barrier, and virtually evans blue is bound to serum albumin. In 
case of systemically injected evans blue is detected in brain suggest that BBB has been 
destroyed. In MCAo animal model (Fig. 16), BBB destruction was maximized at 24 
hours (Fig. 17 d, f-h) after stroke and verified at least 72 hours (Fig. 17 e). Destruction of 
BBB is jeopardized, but can be used to access point to exogenous cell delivery route. 
 
8.  Tracking cell migrating path 
 
We injected ZnMNP-NSCs in internal carotid artery 24 hours after initial stroke attack 
and forced to engraft and migrate to ischemic region by use of magnetic field. Non-
invasive temporal tracking of exogenous cells by MRI, clearly showed migrating path via 
external capsule (EC; Fig. 18 k-l) in magnet guided group. Non guided group showed less 
exogenous cells in quantity and scope (Fig. 18 f-i). 
In order to ensure that the MRI data fits, histological experiment was conducted. 
Human cytoplasm specific peroxidase staining with perl`s prussian blue staining showed 
same cellular path with MR images (Fig. 18 e, j, o, p). 
Minimum density of cells (1,000 cells/mm3) were required in order to be detected by 
MRI (Fig. 3 i, j). High density of cells are settled in EC (Fig. 18) in magnet guided group 
same as MRI. However, we found low density of exogenous cells spread-out the area of 
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Figure 16. Increased neuronal differentiation of ZnMNP-NSCs in vivo. ZnMNP-
NSCs and controls were transplanted to SVZ of the intact rat brain. (a-c), Many Prussian 
blue positive grafted cells were found in CC. The brain sections were counter stained with 
NFR. (d-f), Many hNuc-positive grafted cells (red) were detected in CC. (g-i), The 
number of both hNuc- and Tuj1- positive grafted cells in ZnMNP were highly increased 
compared to those in NSCs and FeMNP. Neural stem cell fate indicating markers were 
immunostained with hNuc. Nestin (k-m), GFAP (n-p), Tuj1 (q-s), PDGFRα (t-v). All 
data represent mean ± SEM. * p < 0.05 compared to NSCs-injected group.  
 
『Abbreviation』 SVZ; subventricular zone, Cx; cerebral cortex, CC; corpus callosum, V; 
lateral ventricle, PB; Perl`s Prussian blue, NFR; nuclear fast red. 
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Figure 17. Blood brain barrier disruption in stroke. (a, b), To visualize BBB 
disruption in stroke brain, evans blue dye (100 mg/kg) was injected to femoral vein of 
adult rat. (c), There was no evans blue extravasation in normal brain tissue. (d, e) The 
leakage of evans blue dye was detected in the ipsilateral hemisphere to stroke at 24 hours 
post-infarction. A cross section of the brain at 24 hours post-infarction (f, g) and TTC 
staining (h) revealed the disrupted BBB area (arrowheads).  
 
『Abbreviation』 BBB; blood brain barrier, TTC; 2,3,5-Triphenyltetrazolium chloride 
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Figure 18. MR based in vivo tracking of cellular path in stroke brain. (a-d), 
Representative serial T2 MR brain images of vehicle injection groups. (f-i), 
Representative serial T2 MR brain images of ZnMNP-NSCs injection group without 
magnetic field. (k-n), Representative serial T2 MR brain images of ZnMNP-NSCs 
injection group with magnetic field. (e, j, o), human specific cytoplasm (sc121) 
immunostaining with Perl`s prussian blue staining immediately after last MR imaging. 
(p), Under high magnification of (o). 
 
『Abbreviation』 MR; magnetic resonance 
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Figure 19. In vivo histological tracking of ZnMNP-NSCs following cell injection into 
stroke brain. (a), Schematic pictures showing the magnet guided migration route of 
injected ZnNP-NSCs. (b), Schematic pictures showing the non guided migration route of 
injected ZnNP-NSCs. (c), Schematic pictures showing the migration route of injected 
NSCs. (d-f), Magnet guided engrafted cells were settled in cx, st, ec. (g, h), Non guided 
engrafted cells were settled in fornix. (i-k), Most of labeled ZnMNP (blue, indicated by 
arrowhead) were remained in NSCs (brown) when analyzed at 3 weeks following cell 
injection. (l-q), Magnet guided engrafted cells were differentiated into multiple lineages; 
NSCs (l), astrocyte (m), oligodendrocyte (n), neurons (o-q). Whether magnet was 
presence or not, ZnMNP-NSCs were forced to neuronal differentiation (r). All data 
represent mean ± SEM.  * p < 0.05 compared to NSCs injected group.   
 
『Abbreviation』 cx; cerebral cortex, st; striatum, ec; external capsule 
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Table 6. Differentiation pattern of Zn-doped magnetic nanoparticle-neural stem 
cells in stroke brain 
 NSCs ZnMNP-NSCs ZnMNP-NSCs-MF 
Nestin 85.03±3.01 81.98±1.65 83.01±1.26 
GFAP 86.26±2.09 77.85±2.29 79.14±3.12 
Tuj1 5.96±1.36 23.24±1.74* 25.94±2.43* 
 
All data were expressed as mean±SEM. and as a percentage of the hNuc-positive cells. 
* p < 0.05 compared to NSCs injected group. 
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ischemic core and penumbra region including cerebral cortex and striatum (Fig. 19 d,e). 
These cells express human specific marker (hNuc) with neural stem cell fate specific 
markers (nestin, GFAP, PDGFα, Tuj1, Dcx, Map2; Fig. 19 l-q). As with previous studies, 
neuronal marker Tuj1 was increased in ZnMNP-NSCs injected group whether magnet 
was present or not (Fig. 19 r, Table. 6) 
Next, human cytoplasm specific peroxidase staining with Perl`s prussian blue staining 
was carried out. This image showed that ZnMNP  remained in exogenous cells (Fig. 19 
i-k) 
 
9.  Measuring engrafted cell quantities 
 
Some animals were given ZnMNP-Lenti-Fluc-GFP-NSCs as same as ZnMNP-NSCs. 
Normally, Fluc had no cellular functions, but treated with D-luciferin emitting a wave 
signal of near-infrared. Fluc activating signal (Photons/sec/cm2/sr) and the number of 
Fluc cells were directly proportional, following standard primary function curve (Fig. 2 g ;  
y=0.0238x + 297.8). Therefore, engrafted cell number can be calculated by the 
mathematical formula. Approximately, 60 times of Fluc activity was measured in magnet 
guided group in 3 weeks after injection, which suggest 60 times of cells were engrated 
compared to non guided cells (Fig. 20 j, Table. 7) 
 
10.  Therapeutic effect 
 
The initial brain stroke attack is resulting in serious damage. The pathogenic process 
leading from the initial brain stroke is getting worse, because of infarct evolution. Clearly, 
infarction volume in magnet guided group was not replaced. But in control groups, 
infarction area was steadily increased. By contrast, in magnet guided group, infarct 
evolution was inhibited (Fig. 21 a, Table. 8). 
Assymetric cylinder test which is designed to evaluate locomoter of CNS disorders. In 
MCAo animal model, impaired forelimb meant damaged brain hemisphere related fore 
limb function is reduced. Assymetric cylinder testdata showed improved neurological 
performance in magnet guided group compared to controls (Fig. 21 b, Table. 9). 
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Figure 20. Engraftment of injected cells in stroke brain. (a-c), Vehicle injection 
groups showed bottom level of luciferase signals. (d-f), Luciferase signals in ZnMNP-
NSCs without magnetic field group according to time intervals. (g-i), Luciferase signals 
in ZnMNP-NSCs with magnetic field group according to time intervals. (j), Quantitative 
ROI analysis that the engraftment of live cells into ischemic brain. All data represent 
mean ± SEM. * p < 0.05 compared to vehicle-injected group, † p < 0.05 compared to w/o 
MF. 
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Table 7. Engraftment of magnet guided Zn-doped magnetic nanoparticle-neural 
stem cells in stroke brain 
 
 Week1 w/o MF (n=7) 
w MF 
(n=8) 
Luciferase 
intensity2 
1 2,720±313.74 530,000±203,071.3* 
3 1,610±147.46 556,000±184,848.6* 
Common 
logarithm 
of 
luciferase 
intensity3 
1 3.43±0.05 5.70±0.22* 
3 3.20±0.04 5.68±0.19* 
Assumed 
Cell 
Number4 
1 79,800±2,290 3,930,000±1,482,420* 
3 71,800±1,076 4,120,000±1,349,394* 
Percentage 
of Cell 
Number5 
1 0.26 13.10* 
3 0.24 13.73* 
 
1 Weeks after cell injection. 
2 Fluc signal intensity, Photons/sec/cm2/sr. 
3 Log10 scale of Fluc signal intensity. 
4 Assumed cell number based on standard curve. 
5 Assumed cell number as a percentage of total injected cell number. 
All data were expressed as mean±SEM. * p < 0.05 compared to w/o MF. 
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Figure 21. Therapeutic potentials of magnetically guided ZnMNP-NSCs in ischemic 
brain. (a), Cerebral infarct volume was significantly reduced in the magnet-guided group 
compared to the non-magnet-guided (w/o MF) or vehicle-injected group at 3 weeks 
following injection. (b), Asymmetric cylinder test showed the significant improved motor 
performance in the magnet-guided cell group (w MF) at 3 weeks following cell injection 
to stroke brain compared to vehicle-injected group. (c), Area of contralateral cerebral 
hemisphere. (d), Area of infarct in the ipsilateral hemisphere to stroke. All data represent 
mean ± SEM. * p < 0.05 compared to vehicle-injected group, † p < 0.05 compared to w/o 
MF. # p < 0.05 compared to the first collected data in the same group. 
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Table 8. Infarction volume measurement 
 
Day1 Vehicle (n=8) 
w/o MF 
(n=18) 
w MF 
(n=9) 
1 27.72±1.37 26.18±1.17 25.79±0.94 
7 32.11±2.65 30.03±1.55 27.48±1.30 
21 40.71±4.75# 35.45±1.92 27.85±1.33*† 
Rate2 1.43±0.09 1.36±0.67 1.08±0.04*† 
 
1  Days after cell injection. 
2 Increasing rate of infarction at Day21 measurement as a percentage of Day1 
measurement. 
 
All data were expressed as mean±SEM. * p < 0.05 compared to vehicle-injected group, † 
p < 0.05 compared to w/o MF, # p < 0.05 compared to the first collected data in the same 
group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
Table 9. Assymetric neurological cylinder test  
 
Day1 Vehicle (n=8) 
w/o MF 
(n=17) 
w MF 
(n=9) 
1 21.64±0.89 26.64±0.90 19.80±1.32 
7 21.18±1.01 21.86±1.43 22.11±1.08 
21 21.34±1.54 23.33±1.31 28.96±1.41*# 
 
1 Days after cell injection. 
All data were expressed as mean±SEM. * p < 0.05 compared to vehicle-injected group. # 
p < 0.05 compared to the first collected data in the same group. 
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IV. DISCUSSION 
 
Over the past decades, medical breakthroughs had improved the survival rate 
of brain stroke attack. Blood supplies were restored by use of recombinant tissue 
plasminogen activator (rt-PA) or antiplatelet medicines. Nevertheless, survivals 
suffered by impairment of sensation, movement or cognition because the 
damaged brain tissue has short ability of restoration. 
The brain continues to produce new cells throughout life and these appear to 
be capable of taking on normal functions. However, brain cannot produce 
sufficient amount of cells in the injury of brain including ischemia. Therefore, 
we should fill in the insufficient production of new cells generated by exogenous 
neural stem cells. But transplanted neural stem cells cannot produce enough new 
neurons and cannot secure cell viability likewise endogenous cellular source, 
because of the harsh biological microenvironments in areas of pathology. 
Researchers attempts to overcome such limitations, NSCs were transplanted far 
apart from those target lesions but chemoattractive mechanisms were limited 
owing to complicated chemoattractive mechanisms. 
As an alternative solution to the chemotaxis, magnetotaxis is an effective cell 
manipulating method. ZnMNP gave rise magnetotactic ability to neural stem 
cells. ZnMNP-NSCs were capable of migration toward to magnet 12μm/hour in 
intact brain. Systemically injected magnetotactic NSCs through carotid artery 
and guided by magnet can expect a similar delivery efficiency of intracerebral 
cell transplantation in live animal while avoiding invasive craniectomy. In 
addition, ZnMNP did not alter cell proliferation, cytotoxicity and neurosphere 
morphology. 
Unexpectedly, in genetic screening by use of traditional PCR, we found 
different gene expressing pattern. Proneural transcription factors and neuronal 
gene expression level were increased. Same results came out from 
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immunocytochemistry, Q-PCR, western blotting, and immuno histochemistry. 
Through the wnt signaling antagonist DKK1 treating, we realized the 
involvement of wnt signaling pathway. WNT signaling has a crucial role in early 
development through the regulation of cell fate decision, cell movement and 
tissue polarization.59,60 In the central nervous system, Wnt signaling has been 
implicated in the neurogenesis, axon remodeling, dendrite and synapse 
formation. In xenopus system, zinc finger transcription factor ZIC family were 
known as wnt signaling pathway activator. We found ZIC1 and ZIC2 increament 
in ZnMNP-NSCs, while ZIC3, ZIC4, ZIC5 reveal no difference. Wnt reporting 
gene, AXIN2 was increased, either. There were several strong evidences of wnt 
signaling involvement ; DKK1, Wnt ligands, ZIC transcription factors, β-catenin. 
In addition, ZnMNP showed augmented of NGF, NTF3 secretion compared to 
controls. NGF is a representative neurotrophic factor known as the function of 
survival of neurons.61,62 NTF3 is known as not only neurotrophic effects but also 
immunomodulatory factor.61,63 
We found ZIC transcription factors between ZnMNP and wnt signaling 
pathway. In xenopus system, Zic1 is an activator of wnt signaling pathway.64 
However, we did not find the relation between ZnMNP and ZIC transcription 
factors. Possible mechanisms are Zn ion concentrations but Zn ion concentration 
showed no significant changes in ZnMNP-NSCs (Fig. 5). One reason for this 
assumption is the lack of zinc ion inhibit the neurogenesis and brain 
formation.24,25 For now, less than the ion level that can be detected, may activate 
the ZIC transcription factors.  
Brain ischemia is accompanied by the destruction of the BBB.40 Destruction 
of BBB is jeopardized, but can be used to access point to exogenous cells. 
Therefore, we injected ZnMNP-NSCs in internal carotid artery. Magnet guided 
injected cells were concentrated to BBB destructed area and penetrated into the 
brain and spread to ischemic core and penumbra area. 
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Therapeutic effect of NSCs vary depending on the number of cells at areas of 
pathology. Magnet guided cell delivery methods revealed 60 times effective 
delivery (Table. 6) rate than non-guided cell injection group. As a result, 
therapeutic effects of magnet guided group were better than non-guided group in 
infarct volume measurement and neurological cylinder test (Fig. 21, Table. 8, 
Table. 9). 
ZnMNP promote NSCs neurogenesis in a stepwise process (Fig. 15) and give 
rise to superparamagnetic ability to NSCs (Fig. 6-7). Both features synergize the 
therapeutic effect of stroke brain. It was reported that grafted NSCs derived 
neurons exhibit synaptic integration into host neural circuitries.9,41 Our data 
show increased neurogenesis through wnt signaling pathway (Fig. 12-15), 
suggesting that neuronal replacement may contributed to improvement. 
Superparamagnetic features enhance the number of grafted NSCs and NSCs-
derived neurons (Fig. 20, Table. 6, Table. 7).  Indeed, this property facilitates 
MRI based cell tracking. 
NSCs secrete several neurotrophic factors such as NGF, NTF3, NTF4, GDNF, 
BDNF.65 Western blot analysis reveal increased secretion of NGF and NTF3 in 
ZnMNP-NSCs compared to controls (Fig. 14). Some reports NGF secretion was 
related to Wnt3a62,65 and NTF-3 secretion was related to Wnt1.63,65 These data 
indicate that ZnMNP-NSCs provide large amount of NFG and NFT3 to ischemic 
brain. NTF4, BDNF, GDNF secretion level showed no difference among all 
groups in vitro, but based on the number of engrafted cells, we assumed that 
NTF4, BDNF, GDNF were also provided large quantities to ischemic brain. 
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Figure 22. Magnetic nanoparticles control neural stem cell behavior in ischemic 
stroke. ZnMNP-labeled NSCs are non-invasively injected via the internal carotid artery 
to rat stroke brain. In the presence of external magnetic field, ZnMNP-NSCs exhibit the 
specific migration toward the ischemic regions, robust engraftment within the injured 
regions, and neuronal differentiation which replace damaged neurons and secrete 
neuroprotective factors. Consequently, animals show the decreased cerebral infarct 
volume and improved of motor function. In contrast, injected NSCs exhibit poor in vivo 
control of migration, engraftment and differentiation which subsequently show little 
therapeutic benefits.  
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V. CONCLUSION 
 
This study showed several improvement compared to traditional stem cell therapies. 
First, cells are capable of magnet guided delivery to ischemic region. It enables effective 
cell delivery to central nervous system without craniectomy. This magnetotactic delivery 
is superior to chemotactic delivery. Mangetotatic delivery required no genetic nor 
chemical injections and easy to remove. Second, cell delivery process and monitoring 
process were minimally-invasive. By use of MRI, cellular location were traced in real 
time and at the same time, pathologic process could be monitored. Third, wnt signaling 
mediated neurogenesis is occurred without any genetic modifications nor biochemical 
treatment. Consequently, we remote control of NSCs migration, engraftment, 
neurogenesis and tracking in vivo by use of superparamagnetic nanoparticle and static 
magnetic field. This research is applicable to other neurological disorders such as 
traumatic brain injury, hypoxia ischemic injury and spinal cord injury.  
ZnMNP has tremendous possibilities. This particle can be combined with various of 
biochemical molecules such as DNA, RNA, proteins and easily transfected to cells and 
no cytotoxicity. Traditional delivery methods such as viral delivery, electroporated 
delivery, liposome based methods have the limits. Viral delivery showed high efficiency 
but did not deviated from the arguing about safety issues. Viral materials caused immune-
reponse or cancer by random genetic manipulation. In 1999, Jesse Gelsinger, 18 years old, 
suffered from ornithine transcarbamylase deficiency, was died in a phase I clinical trial 
for gene therapy using adenoviral vector by the University of Pennsylvania.66 In 2000, 
One SCID patient took the leukemia during the clinical trial for gene therapy in France.66 
By contrast, non viral delivery methods are secured about safety issues but gene delivery 
efficiency is not good. ZnMNP transfection shows the efficiency of 95% (Fig. 4 e). By 
using ZnMNP as a gene delivery vector, both delivery efficiency and safety are secured.  
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NSCs possess various therapeutic potentials. NSCs can migrate to desired area, 
generate new neurons or glial cells, replace damaged cells. In addition, therapeutic 
neurotrophic factors such as NGF, NTF3, NTF4, BDNF, GDNF, VEGF and FGF are 
secreted by NSCs. Besides, several anti-inflammatory molecules are originated from 
NSCs. Applying the gene delivery ability of ZnMNP`s to NSCs, various genetic 
modificated therapeutic NSCs will be presented to the treatment of various diseases. 
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ABSTRACT (IN KOREAN) 
 
자성나노입자를 통한 신경줄기세포의 뇌내 제어조절 
 
<지도교수 박 국 인> 
 
연세대학교 대학원 의과학과 
 
윤 석 환 
 
  지난 20여 년간의 연구를 통하여 한 번 손상되면 재생되지 않는 것으로 알
려져 있는 포유류의 중추신경계에 내인성 신경줄기세포의 존재가 밝혀졌다. 
신경줄기세포는 미분화된 상태로 계속 증식하는 자가갱신을 보이고, 다양한 
신경원세포 및 교세포로 분화하는 특성을 보이므로, 뇌졸중을 비롯한 중추신
경계 질환 치료에 적용할 경우, 사멸한 신경세포를 대체하고, 손상된 신경회로
를 재건하여 신경재생을 유도하는 가능성을 보인다. 그럼에도 불구하고, 신경
줄기세포 이식치료시 손상된 신경부위로의 이주 및 생착, 손상된 신경세포 부
위에서의 신생 신경세포생성을 제어할 수 없어 치료적 유용성은 제한적이다. 
  최근 나노기술은 세포를 제어 및 조절 가능한 수준으로 발달하고 있으며, 
탄소나노튜브나 나노형광물질, 자성나노입자가 이미 줄기세포의 추적, 분화 및 
이식 연구에 활발하게 사용되고 있다. 
본 연구에서는 초고감도 자성나노입자를 신경줄기세포에 도입하여, 외부 자
기장에 의해서 생체 내 신경줄기세포의 위치를 제어/조절 할 수 있고, MRI에 
의해 세포의 위치를 추적할 수 있으며, Wnt 신호전달 기작에 의해서 신경원세
포로 분화가 가능하도록 하였다. 상기의 신경줄기세포를 뇌졸중 동물 모델의 
경동맥에 주입하고 외부 자기장에 노출시켰을 때, 주입된 세포는 손상된 뇌조
직으로 효과적으로 이주 및 생착하였고, 신경원세포로 분화하고, 신경영양인자
를 뇌손상 조직에 공급하여 뇌손상 용적의 증가를 억제하였으며, 신경행동의 
개선을 보였다. 
핵심되는 말 : 자성나노입자, 신경줄기세포, 뇌졸중, 세포치료, 주자성 
